• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Cabaletta Bio

< Previous 1 2 Next >
News headline image
Cabaletta Bio Reports First Quarter 2026 Financial Results and Provides Business Update
May 14, 2026
From Cabaletta Bio
Via GlobeNewswire
Tickers CABA
News headline image
Cabaletta Bio Presents Preconditioning-free Clinical Data and Automated Manufacturing Translational Data for Rese-cel at ASGCT 2026 Annual Meeting
May 14, 2026
From Cabaletta Bio
Via GlobeNewswire
Tickers CABA
News headline image
Cabaletta Bio Announces Pricing of $150 Million Underwritten Offering
May 04, 2026
From Cabaletta Bio
Via GlobeNewswire
Tickers CABA
News headline image
Cabaletta Bio and Cellares Announce 10-Year Commercial Supply Agreement for Rese-cel
April 28, 2026
From Cabaletta Bio
Via GlobeNewswire
Tickers CABA
News headline image
Cabaletta Bio Announces Multiple Upcoming Presentations, Including Data on Rese-cel without Preconditioning and Rese-cel with Automated Manufacturing, at the ASGCT 2026 Annual Meeting
April 27, 2026
From Cabaletta Bio
Via GlobeNewswire
Tickers CABA
News headline image
Cabaletta Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
March 23, 2026
From Cabaletta Bio
Via GlobeNewswire
Tickers CABA
News headline image
Cabaletta Bio to Participate in the TD Cowen 46th Annual Health Care Conference
February 24, 2026
From Cabaletta Bio
Via GlobeNewswire
Tickers CABA
News headline image
Cabaletta Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
February 05, 2026
From Cabaletta Bio
Via GlobeNewswire
Tickers CABA
News headline image
Cabaletta Bio Announces 2026 Strategic Priorities
January 12, 2026
From Cabaletta Bio
Via GlobeNewswire
Tickers CABA
News headline image
Cabaletta Bio Reports Third Quarter 2025 Financial Results and Provides Business Update
November 10, 2025
From Cabaletta Bio
Via GlobeNewswire
Tickers CABA
News headline image
Cabaletta Bio to Participate in Upcoming Investor Conferences in November and December
November 04, 2025
From Cabaletta Bio
Via GlobeNewswire
Tickers CABA
News headline image
Cabaletta Bio Presents Positive Clinical Data and Development Updates for Rese-cel at ACR Convergence 2025
October 27, 2025
From Cabaletta Bio
Via GlobeNewswire
Tickers CABA
News headline image
Cabaletta Bio Announces Appointment of Steve Gavel as Chief Commercial Officer and Award of Inducement Grant
October 14, 2025
From Cabaletta Bio
Via GlobeNewswire
Tickers CABA
News headline image
Cabaletta Bio Presents First Rese-cel Data with No Preconditioning Demonstrating Biologic Activity and Early Clinical Responses at the 2025 ESGCT Annual Congress
October 09, 2025
From Cabaletta Bio
Via GlobeNewswire
Tickers CABA
News headline image
Cabaletta Bio to Participate in Upcoming Investor Conferences in September
August 27, 2025
From Cabaletta Bio
Via GlobeNewswire
Tickers CABA
News headline image
Cabaletta Bio Reports Second Quarter 2025 Financial Results and Provides Business Update
August 07, 2025
From Cabaletta Bio
Via GlobeNewswire
Tickers CABA
News headline image
Cabaletta Bio Announces Pricing of Public Offering of Securities
June 11, 2025
From Cabaletta Bio
Via GlobeNewswire
Tickers CABA
News headline image
Cabaletta Bio Announces Proposed Public Offering of Securities
June 11, 2025
From Cabaletta Bio
Via GlobeNewswire
Tickers CABA
News headline image
Cabaletta Bio Announces New Rese-cel Safety and Efficacy Data in Patients with Myositis, Lupus and Scleroderma to Be Presented at the EULAR 2025 Congress
June 11, 2025
From Cabaletta Bio
Via GlobeNewswire
Tickers CABA
News headline image
Cabaletta Bio to Participate in the Jefferies Global Healthcare Conference
May 29, 2025
From Cabaletta Bio
Via GlobeNewswire
Tickers CABA
News headline image
Cabaletta Bio Announces 2027 Rese-cel BLA Submission Anticipated in Myositis Following Recent FDA Alignment on Registrational Cohorts
May 15, 2025
From Cabaletta Bio
Via GlobeNewswire
Tickers CABA
News headline image
Cabaletta Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
March 31, 2025
From Cabaletta Bio
Via GlobeNewswire
Tickers CABA
News headline image
Cabaletta Bio to Participate in the TD Cowen 45th Annual Health Care Conference
February 26, 2025
From Cabaletta Bio
Via GlobeNewswire
Tickers CABA
News headline image
UPDATE - Cabaletta Bio Announces Updated Clinical Data Demonstrating Deepening Clinical Responses across Multiple Indications with Rese-cel at February Scientific Meetings
February 18, 2025
From Cabaletta Bio
Via GlobeNewswire
Tickers CABA
News headline image
Cabaletta Bio Announces Updated Clinical Data Demonstrating Deepening Clinical Responses across Multiple Indications with Rese-cel at February Scientific Meetings
February 18, 2025
From Cabaletta Bio
Via GlobeNewswire
Tickers CABA
News headline image
Cabaletta Bio Announces Presentations Featuring Updated Clinical Data on Rese-cel at Upcoming Scientific Meetings in February
February 11, 2025
From Cabaletta Bio
Via GlobeNewswire
Tickers CABA
News headline image
Cabaletta Bio to Participate in Guggenheim’s SMID Cap Biotech Conference
January 29, 2025
From Cabaletta Bio
Via GlobeNewswire
Tickers CABA
News headline image
Cabaletta Bio Outlines Strategic Priorities and Anticipated Key Milestones for 2025
January 13, 2025
From Cabaletta Bio
Via GlobeNewswire
Tickers CABA
News headline image
Cabaletta Bio to Participate in Upcoming Investor Conferences in December
November 26, 2024
From Cabaletta Bio
Via GlobeNewswire
Tickers CABA
News headline image
Cabaletta Bio Presents Positive Clinical Safety and Efficacy Data on CABA-201 at ACR Convergence 2024
November 18, 2024
From Cabaletta Bio
Via GlobeNewswire
Tickers CABA
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap